These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 17990345)
1. Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis. El Haj M; Ben Ya'acov A; Lalazar G; Ilan Y World J Gastroenterol; 2007 Nov; 13(44):5799-804. PubMed ID: 17990345 [TBL] [Abstract][Full Text] [Related]
2. Glycolipids as immune modulatory tools. Lalazar G; Preston S; Zigmond E; Ben Yáacov A; Ilan Y Mini Rev Med Chem; 2006 Nov; 6(11):1249-53. PubMed ID: 17100636 [TBL] [Abstract][Full Text] [Related]
3. Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders. Zigmond E; Preston S; Pappo O; Lalazar G; Margalit M; Shalev Z; Zolotarov L; Friedman D; Alper R; Ilan Y Gut; 2007 Jan; 56(1):82-9. PubMed ID: 17172586 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases. Miyake S; Yamamura T Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep; 5(3):315-22. PubMed ID: 16178791 [TBL] [Abstract][Full Text] [Related]
5. NKT lymphocyte polarization determined by microenvironment signaling: a role for CD8+ lymphocytes and beta-glycosphingolipids. Zigmond E; Shalev Z; Pappo O; Alper R; Zolotarov L; Ilan Y J Autoimmun; 2008 Sep; 31(2):188-95. PubMed ID: 18710796 [TBL] [Abstract][Full Text] [Related]
6. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids. Parekh VV; Singh AK; Wilson MT; Olivares-Villagómez D; Bezbradica JS; Inazawa H; Ehara H; Sakai T; Serizawa I; Wu L; Wang CR; Joyce S; Van Kaer L J Immunol; 2004 Sep; 173(6):3693-706. PubMed ID: 15356115 [TBL] [Abstract][Full Text] [Related]
7. beta-Glycosphingolipids as immune modulators. Adar T; Ilan Y J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392 [TBL] [Abstract][Full Text] [Related]
8. Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping. Lalazar G; Ben Ya'acov A; Eliakim-Raz N; Livovsky DM; Pappo O; Preston S; Zolotarov L; Ilan Y J Lipid Res; 2008 Sep; 49(9):1884-93. PubMed ID: 18480029 [TBL] [Abstract][Full Text] [Related]
9. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte. Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with ligands of natural killer T cells. Wilson MT; Singh AK; Van Kaer L Trends Mol Med; 2002 May; 8(5):225-31. PubMed ID: 12067632 [TBL] [Abstract][Full Text] [Related]
11. Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands. Tsuji M Cell Mol Life Sci; 2006 Aug; 63(16):1889-98. PubMed ID: 16794785 [TBL] [Abstract][Full Text] [Related]
12. Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice. Ueno Y; Tanaka S; Sumii M; Miyake S; Tazuma S; Taniguchi M; Yamamura T; Chayama K Inflamm Bowel Dis; 2005 Jan; 11(1):35-41. PubMed ID: 15674111 [TBL] [Abstract][Full Text] [Related]
13. Application of natural killer T cells in antitumor immunotherapy. Hong C; Park SH Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797 [TBL] [Abstract][Full Text] [Related]
14. Administration of beta-glycolipids overcomes an unfavorable nutritional dependent host milieu: a role for a soy-free diet and natural ligands in intrahepatic CD8+ lymphocyte trapping and NKT cell redistribution. Livovsky DM; Lalazar G; Ben Ya'acov A; Pappo O; Preston S; Zolotaryova L; Ilan Y Int Immunopharmacol; 2008 Sep; 8(9):1298-305. PubMed ID: 18602077 [TBL] [Abstract][Full Text] [Related]
15. CD1d-mediated antigen presentation to natural killer T (NKT) cells. Brutkiewicz RR; Lin Y; Cho S; Hwang YK; Sriram V; Roberts TJ Crit Rev Immunol; 2003; 23(5-6):403-19. PubMed ID: 15030309 [TBL] [Abstract][Full Text] [Related]
16. NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune disease. Yamamura T; Miyamoto K; Illés Z; Pál E; Araki M; Miyake S Curr Top Med Chem; 2004; 4(5):561-7. PubMed ID: 14965307 [TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis. Shibolet O; Kalish Y; Klein A; Alper R; Zolotarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y J Leukoc Biol; 2004 Jan; 75(1):76-86. PubMed ID: 14557387 [TBL] [Abstract][Full Text] [Related]
18. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation. Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555 [TBL] [Abstract][Full Text] [Related]
19. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Cardell SL Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042 [TBL] [Abstract][Full Text] [Related]
20. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Miyamoto K; Miyake S; Yamamura T Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]